You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 3, MARCH 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PAROXYSMAL VENTRICULAR TACHYCARDIA TREATED WITH INTRAVENOUS INJECTIONS OF QUINIDINE

LEWIS E. JANUARY, M.D; HENRY E. HAMILTON, M.D.; DAVID W. SINTON, M.D.

AMA Arch Intern Med. 1953;91(3):325-332.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE INTRAVENOUS administration of quinidine has not been accepted generally because of serious reactions following its use by this route.1 Although intravenous quinidine preparations are known to be effective in terminating paroxysmal ventricular tachycardia,2 their use has been delayed because serious sideeffects have occurred when they have been given for this purpose.3 There are few reports describing its use in a significant number of attacks of ventricular tachycardia. Hepburn and Rykert2g recorded nine instances, and normal sinus rhythm was restored in eight. Recently Armbrust and Levine,2a in analyzing 107 cases of paroxysmal ventricular tachycardia, described 31 attacks treated with intravenous quinidine. In 20 of the attacks, conversion to normal sinus rhythm occurred at a time which indicated a response to quinidine therapy. Herrmann and Hejtmancik2f found it effective in two of three cases, and Clagett2b successfully treated three patients. Strong and Munroe2e and, more recently, Bell and his associates2c have . . . [Full Text PDF of this Article]


Author Affiliations

IOWA CITY

From the Department of Internal Medicine, College of Medicine, State University of Iowa, Iowa City.


Footnotes

The quinidine lactate and quinidine gluconate used in this study were supplied through the courtesy of Eli Lilly & Company, Indianapolis.

Read at the 25th Annual Meeting of the Central Society for Clinical Research, Chicago, Nov. 8, 1952, and abstracted in the Proceedings of that Society (J. Lab. & Clin. Med. 40:814, 1952).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.